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The cell biological principles that govern innate
immune responses in Drosophila are unknown.
Here, we report that Toll signaling in flies was
dictated by the subcellular localization of the adaptor
protein dMyD88. dMyD88 was located at the plasma
membrane by a process dependent on a C-terminal
phosphoinositide-binding domain. In vivo analysis
revealed that lipid binding by dMyD88was necessary
for its antimicrobial and developmental functions as
well as for the recruitment of the downstream cyto-
solic adaptor Tube to the cell surface. These data
are reminiscent of the interactions between the
mammalian Toll adaptors MyD88 and TIRAP with
one major exception. In the mammalian system,
MyD88 is the cytosolic adaptor that depends on the
phosphoinositide-binding protein TIRAP for its
recruitment to the cell surface. We therefore propose
that dMyD88 is the functional homolog of TIRAP and
that both proteins function as sorting adaptors to
recruit downstream signaling adaptors to activated
receptors.
INTRODUCTION
An emerging theme in the study of innate immune signal trans-
duction is the importance of subcellular localization for protein
function. Observations in support of this claim were first made
through the study of the Toll-like receptors (TLRs), which can
be found at the plasmamembrane as well as on various endoso-
mal organelles (Barton and Kagan, 2009). Recently, this principle
has been extended to the cytosolic signaling proteins that act
downstream from TLRs (Kagan and Medzhitov, 2006; Kagan
et al., 2008; Rowe et al., 2006). It is at this level that the first
mechanistic insight has come to explain the link between subcel-
lular localization and protein function. For example, TLR4 acti-
vates two signaling pathways that are dictated by the localization
of the TIR domain-containing adaptor pairs, TIRAP-MyD88 and
TRAM-TRIF (Barton and Kagan, 2009). Signaling induced by
the TIRAP-MyD88 pair occurs from the cell surface andmediates
the expression of inflammatory cytokines by a process
dependent on NF-kB and AP-1 (Horng et al., 2002; Kagan and612 Immunity 36, 612–622, April 20, 2012 ª2012 Elsevier Inc.Medzhitov, 2006; Yamamoto et al., 2002). TIRAP contains
a lipid-binding domain that permits its localization to phosphati-
dylinositol 4,5-bisphosphate (PIP2)-rich regions of the plasma
membrane (Kagan and Medzhitov, 2006). By binding these
PIP2-rich regions of the cell surface, TIRAP is positioned to
recruit, or ‘‘sort,’’ MyD88 to this location in order to promote
signaling. Whereas MyD88 interacts directly with the down-
stream enzyme IRAK4 to induce signal transduction, TIRAP
cannot. Thus, TIRAP is considered a sorting adaptor, whose
primary function is to deliver the signaling adaptor MyD88 to
plasma membrane-localized TLRs (Barton and Kagan, 2009).
Similar cell biological rules can be applied to the other TIR-con-
taining adaptor pair, TRAM-TRIF. This adaptor pair mediates the
expression of type I interferons (IFNs) from endosomes after
microbe-induced endocytosis of TLR4 by a process dependent
on IRF3 (Doyle et al., 2002; Kagan et al., 2008; Tanimura et al.,
2008). TRAM contains a bipartite localization motif consisting
of a phosphoinositide-binding domain and a myristoylation
motif, which permits its delivery to the plasma membrane and
endosomes (Kagan et al., 2008; Rowe et al., 2006). It is from
this latter location that TRAM engages activated TLR4 and
induces the recruitment of TRIF (Kagan et al., 2008; Tanimura
et al., 2008). Like MyD88, TRIF is a bona fide signaling adaptor
in that it interacts directly with downstream signaling enzymes,
such as the E3 ubiquitin ligases TRAF3 and TRAF6 (Ha¨cker
et al., 2006; Sato et al., 2003). TRAM cannot directly bind to
these factors. Thus, like TIRAP, TRAM is considered a sorting
adaptor, whose function is to recruit TRIF to endosome-localized
TLR4 to promote signal transduction.
Although the sorting-signaling adaptor paradigm has emerged
as an important regulatory process in mammalian innate immu-
nity, its significance in lower eukaryotes is less clear. The reason
for this confusion is that no known homologs of the sorting
adaptors exist in lower eukaryotes. For example, Drosophila
melanogaster has long been the model organism of choice to
study evolutionary aspects of innate immunity (Hoffmann,
2003), but neither TIRAP nor TRAM have been identified in flies.
Despite the lack of identified sorting adaptors in flies, Drosophila
Toll, like several mammalian TLRs, requires two adaptor mole-
cules to link it to the downstream kinases of the IRAK/Pelle family
(Sun et al., 2002; Sun et al., 2004). Because Drosophila Toll
requires two adaptor proteins, we considered the possibility
that one of these might serve a sorting adaptor function. The
receptor proximal adaptor shows substantial sequence
homology to the mammalian MyD88 protein and thus was
named dMyD88 (or dmMyD88) (Horng and Medzhitov, 2001;
Immunity
dMyD88 Is a Sorting AdaptorTauszig-Delamasure et al., 2002). The other adaptor, Tube, has
no known mammalian homolog. Interestingly, biochemical anal-
ysis indicates that the interactions that the conserved adaptor
MyD88 undergoes during signal transduction differ between
mammals and flies. For example, in mammals, MyD88 binds
directly to IRAK family members (Lin et al., 2010; Motshwene
et al., 2009), but in flies, dMyD88 cannot bind directly to the
IRAK homolog Pelle (Sun et al., 2002). Rather, Tube serves this
function with dMyD88 only binding indirectly to Pelle (Sun
et al., 2002).
Because the known sorting adaptors are not found in lower
eukaryotes, the question remains as to whether the subcellular
positioning of adaptors is only important for Toll signaling in
mammals. Considering that sorting adaptors bind indirectly to
signaling enzymes in mammals, as well as the fact that the
known adaptor protein Tube lies between dMyD88 and Pelle
(Sun et al., 2002), we considered the possibility that MyD88
may have different functions in mammals and flies. We hypothe-
sized that unlike its mammalian namesake, dMyD88 may func-
tion analogously to TIRAP by serving the role of a sorting adaptor
in Drosophila Toll signaling. Herein, we show that dMyD88
contains a C-terminal phosphoinositide-binding motif that
directs it to the plasma membrane. Moreover, we demonstrate
the functional importance of this localization domain in vivo
and establish that signaling is at least initiated from the plasma
membrane by dMyD88’s ability to recruit downstream signaling
components to the cell surface. We propose that the use of sort-
ing-signaling adaptor pairs in Toll signaling predates mammals
and that the cell biological principles that govern innate signaling
pathways represent a fundamental rule throughout evolution.
RESULTS
dMyD88 Is Localized to the Plasma Membrane
A defining feature of mammalian sorting adaptors is their ability
to localize to regions of the cell that contain TLRs even before
signaling has been initiated (Barton and Kagan, 2009; Kagan
and Medzhitov, 2006; Kagan et al., 2008). This function is
thought to facilitate rapid detection of activated receptors and
promote the recruitment of downstream adaptors to these sites.
dMyD88 has been found at the plasma membrane in Drosophila
embryos (Sun et al., 2004), but whether this localization was
simply the result of developmental Toll signaling in vivo is
unknown. To address the intrinsic presignaling localization of
dMyD88, we examined the subcellular distribution of this
adaptor inDrosophila S2 cells. In fly cells, dMyD88 was localized
to the plasma membrane (Figure 1A and Figure S1 available on-
line). Similarly, dMyD88 was found to be enriched at plasma
membrane ruffles in primary mouse macrophages (Figure 1B),
suggesting that dMyD88 does not require any fly-specific factors
for its plasma membrane recruitment. Similar results were ob-
tained when examining the localization of TIRAP (Figure 1B),
whereas mouse MyD88 (mMyD88) was found in foci scattered
throughout the cell (Figure 1B). The fact that dMyD88 localization
appeared similar to that of TIRAP prompted us to investigate
whether these two proteins were recruited to similar regions of
the plasma membrane. To address this question, we examined
the distribution of dMyD88 and TIRAP within the same cell.
dMyD88 and TIRAP were both concentrated at overlappingregions of membrane ruffles in wild-type (WT) mouse macro-
phages (Figure 1C), raising the possibility that these adaptors
utilize a similar mechanism of protein localization. Collectively,
these data indicate that dMyD88 resides at the plasma
membrane and that recruitment of dMyD88 to the cell surface
does not require a fly-specific factor.
dMyD88 Is a Phosphoinositide-Interacting Protein
Sequence homology had originally identified dMyD88 as the
Drosophila homolog of mammalian MyD88 (Horng and Medzhi-
tov, 2001; Tauszig-Delamasure et al., 2002). Both proteins
contain anN-terminal death domain and a TIR domain. However,
unlike itsmammalian counterpart, dMyD88contains aC-terminal
extension (CTE) that does not have similarity to any known
protein domains. We hypothesized that this CTE was respon-
sible for dMyD88 localization to the plasma membrane. To test
this hypothesis, we generated deletion mutants and examined
the resulting proteins for their ability to phenocopy the localiza-
tion of full-length dMyD88. Consistent with our hypothesis, the
CTE was sufficient to phenocopy full-length dMyD88 localization
(Figure 2A). In contrast, dMyD88 mutants lacking the C-terminal
domain (DD + TIR) were cytosolic (Figure 2A). These results
provide evidence that membrane localization of dMyD88 occurs
independently of its signaling domains. Thus, dMyD88 exhibits
a property common to other sorting adaptors, given that both
TIRAP and TRAM use TIR-independent means of membrane
localization (Kagan and Medzhitov, 2006; Kagan et al., 2008;
Rowe et al., 2006).
Examination of the localization motif of dMyD88 revealed that
this region had a higher isoelectric point than the rest of the
protein (10.16 and 6.71, respectively). The localization domains
of TIRAP and TRAM also possess this characteristic, which is
a feature found in domains that bind phospholipids (McLaughlin
et al., 2002). Because both TIRAP and TRAM are phosphoinosi-
tide-interacting proteins (Kagan and Medzhitov, 2006; Kagan
et al., 2008), we performed in vitro protein-lipid interaction
assays to assess the ability of dMyD88 to bind to membrane
lipids. More specifically, we used PIP strips and PIP arrays,
which are commercially available nitrocellulose membranes
that contain a variety of lipid species (Figures 2B and S2).
Glutathione S-transferase (GST)-tagged dMyD88, but not
mouse MyD88, bound detectably to all the negatively charged
phosphoinositides (Figure 2B). This interaction with phosphoino-
sitides was specific, given that dMyD88 did not interact with
unphosphorylated phosphatidylinositol or any of the general
membrane lipid species examined, such as phosphatidyletha-
nolamine, phosphatidylcholine, or phosphatidylserine (Fig-
ure 2B). Consistent with our hypothesis that the C-terminal
localization domain is responsible for this interaction, the CTE
of dMyD88 bound the same phosphoinositides as the full-length
protein (Figure 2B). In contrast, the N-terminal portion of dMyD88
(DD + TIR) was defective for lipid binding in vitro (Figure 2B).
As an independent approach, we examined the ability of
GST-dMyD88 to bind liposomes containing either PI(4)P,
PI(4,5)P2 or PA. GST-dMyD88 interacted preferentially with lipo-
somes containing PI(4,5)P2 and to a lesser extent liposomes
containing PI(4)P (Figure 2C). Similar results were obtained
when the CTE was used in this pull-down assay (data not
shown). Taken together, these data indicate that dMyD88 isImmunity 36, 612–622, April 20, 2012 ª2012 Elsevier Inc. 613
Figure 1. dMyD88 Localizes to the Plasma
Membrane
(A) S2 cells were transfected with FLAG-dMyD88 and
stained with FLAG antibodies.
(B) Fluorescence micrographs of primary mouse macro-
phages transfected with dMyD88-YFP, FLAG-TIRAP, or
FLAG-mMyD88. Cells were costained with FLAG anti-
bodies and Alexa Fluor-647 phalloidin so that F-actin
could be visualized. As evidenced by the costaining with
F-actin in the merged images, dMyD88 and TIRAP both
localize to membrane ruffles.
(C) Fluorescence micrographs of primary mouse macro-
phages expressing TIRAP-GFP and FLAG-dMyD88.
Note that both TIRAP and dMyD88 are concentrated
in overlapping regions of membrane ruffles. All images
are representative of at least three independent experi-
ments where over 500 cells were examined per condition
and >95% of the cells displayed similar staining. Scale
bars represent 5 mm. See also Figure S1.
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responsible for its localization, is also responsible for this
interaction.
The C-terminal Phosphoinositide-Binding Domain of
dMyD88 Is Necessary to Control Infections in Flies
It is very common for phosphoinositide-binding proteins to
exhibit promiscuous binding in vitro, but a single lipid usually
mediates protein localization in vivo (Lemmon, 2003). To deter-614 Immunity 36, 612–622, April 20, 2012 ª2012 Elsevier Inc.mine which lipid species is probably mediating
dMyD88 localization within cells, we generated
a series of chimeric alleles in which the natural
lipid-binding domain was replaced with do-
mains that interact with single phosphoinositi-
des. We focused specifically on lipids that are
found to some extent at the plasma membrane
because this is the natural site of dMyD88 resi-
dence. In S2 cells, chimeric dMyD88 proteins
that bind specifically to PI(4)P through the
attachment of the pleckstrin homology (PH)
domain of FAPP1 did not phenocopy the locali-
zation of the WT allele (Figure S3A). In addition,
neither the PI(3,4,5)P3 specific domains (PH
domain of GRP1) nor the PI(3)P-specific domain
(PX domain of Gp91phox) exhibited a localiza-
tion similar to WT dMyD88 (Figure S3A). In
contrast, the dMyD88 chimera containing
a PI(4,5)P2 (PIP2)-specific PH domain from
PLCd1 (dMyD88-PLC) phenocopied the locali-
zation of the WT protein (Figures 3 and S3A).
The PLCd1 PH domain was chosen for our
studies because it is one of the only known
domains that interact specifically with PIP2
in vitro and in vivo (Lemmon, 2003). This
specificity is due to its unusually high affinity
for this lipid. Thus, the fact that dMyD88-PLC
phenocopied the localization of WT dMyd88
made PIP2 a likely candidate for the in vivo
regulator of dMyD88 localization.To determine whether PIP2 binding by dMyD88 is sufficient for
its signaling functions, we reconstituted dMyD88 mutant flies
with the dMyD88-PLC allele. We also reconstituted dMyD88
mutant flies with the full-length dMyD88 allele (dMyD88-FL) or
an allele lacking its localization domain (dMy88-Cyto). The
collection of these transgenic lines permits the side-by-side
examination of the functional consequence of altering the affinity
of dMyD88 for phosphoinositides, in particular PIP2. All trans-
genic fly lines produced comparable amounts of dMyD88 RNA
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Figure 2. dMyD88 Localization Is Dictated by
a C-terminal Phosphoinositide-Binding Domain
(A) Fluorescence micrographs of S2 cells transfected with
either full-length dMyD88 (FL) or various dMyD88 deletion
mutants. The N-terminal construct (DD+TIR) contains
amino acids 1–386, whereas amino acids 375–537
comprise the CTE construct. Scale bars represent 5 mm.
(B) PIP strips of various lipids (shown in left panel) were
incubated with GST-tagged full-length dMyD88, mouse
MyD88 (mMyD88), and the dMyD88 deletion mutants
described in (A). dMyD88 and its CTE interact with all PIs
tested, whereas mMyD88 and the N-terminus (DD+TIR)
do not.
(C) Quantitative analysis of dMyD88’s ability to bind lipo-
somes containing 18% of the indicated phosphoinositide.
Shown is a representative experiment (n = 6) demon-
strating that dMyD88 interacts preferentially to PIP2 when
compared to other phospholipids. See also Figure S2.
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dMyD88 Is a Sorting Adaptorand their respective dMyD88 proteins (Figures 3C and 3D), and
the alleles used for generating these lines displayed the ex-
pected subcellular distributions in S2 cells (Figure 3B).
Because dMyD88 mutant flies are highly susceptible to infec-
tion by Gram-positive bacteria (Kambris et al., 2003; Tauszig-
Delamasure et al., 2002), the transgenic lines were tested for
their ability to rescue this immune phenotype. None of the
parental lines showed a difference in survival after E. faecalis
infection, suggesting that any variation between the dMyD88
mutant flies complemented with the dMyD88 transgenes reflect
the expression of the various dMyD88 alleles and not the inser-
tion of the transgenes (Figure S3B). As expected, infection by
either E. faecalis or S. epidermidis caused rapid and complete
lethality of dMyD88 mutant flies, and this phenotype was com-
plemented by the expression of full-length dMyD88 (Figures 3E
and 3F). In contrast, flies expressing the cytosolic allele
(dMyD88-Cyto) displayed reduced resistance to infection (Fig-
ures 3E and 3F). These results indicate that plasma membrane
localization is necessary for the immune functions of dMyD88.
Interestingly, dMyD88-PLC flies survived even better than their
dMyD88-FL counterparts (Figures 3E and 3F), suggesting that
PIP2 binding by dMyD88 is sufficient for the immune functions
of this adaptor. The possibility that the PLCd1 PH domain has
any intrinsic signaling functions was ruled out when we assayedImmunity 36its ability to rescue Toll signaling in dMyD88-
deficient S2 cells. Unlike the cells expressing
dMyD88-FL and dMyD88-PLC, no significant
Drosomycin expression was observed in cells
expressing the PLCd1 PH domain alone (Fig-
ure S3C). To confirm that non-Toll immune
pathways were unaffected by the dMyD88
transgenes, infections were performed with the
Gram-negative bacteria E.coli, which is eradi-
cated by the Imd pathway (Leulier et al., 2000).
None of the transgenic lines were sensitive to
infection by E. coli (Figure 3G), whereas the
Imd pathwaymutant kenny succumbed to infec-
tion by this bacteria.
To confirm that the observed survival defect in
dMyD88-Cyto flies resulted from reduced Tollsignaling, we measured the expression of antimicrobial peptides
(AMP) known to be induced following activation of the Toll
pathway (De Gregorio et al., 2002). Consistent with a defect in
Toll signaling, dMyD88 mutant flies expressing dMyD88-Cyto
displayed decreased expression of both Drosomycin (Drs) and
Metchnikowen (Mtk) in response to infection with either
E. faecalis or S. epidermidis (Figures 4A and 4B). However,
induction of Diptericin (Dpt), an AMP induced by the Imd
pathway, was not affected (Figure S4). Interestingly, dMyD88-
PLC displayed higher expression of Toll-activated AMPs both
at baseline and after infection. This observation probably
explains the heightened resistance to bacterial infection ex-
hibited by flies expressing this transgene.
We hypothesized that the differences in survival after infec-
tions may result from an inability to kill and clear the bacteria.
To address this possibility, we challenged male flies with
E. faecalis and homogenized individual flies to measure their
bacterial loads. Consistent with the survival defect, dMyD88-
Cyto flies were unable to control the infection, as a higher bacte-
rial load was observed in these mutant flies when compared to
flies that readily control the infection (FL or PLC counterparts)
(Figure 4C). However, as compared to flies that display
dMyD88 at the plasma membrane (FL or PLC), the bacterial
load in dMyD88-Cyto flies varied greatly from fly to fly with, 612–622, April 20, 2012 ª2012 Elsevier Inc. 615
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Figure 3. Phosphoinositide Binding by dMyD88 Is Necessary for Immune Defenses in Flies
(A) Schematic representation of the dMyD88 constructs used to generate transgenic flies. The molecular weights (MW) of the resulting proteins are indicated.
(B) Fluorescence micrographs of S2 cells expressing the indicated dMyD88 constructs. The localization of full-length dMyD88 (FL) is phenocopied by the PIP2-
specific chimera (dMyD88-PLC). Scale bars represent 5 mm.
(C and D) Lysates from dMyD88 homozygous mutant (c03881), wild-type dMyD88 heterozygote (WT), and dMyD88 homozygous mutant flies complemented
with the transgenes described in (A) were analyzed either by immunoblotting with a dMyD88 antibody (obtained from S. Wassermann [Sun et al., 2002]) or by
performing RT-PCR using dMyD88 Taqman probes. No significant difference in RNA or protein amounts was observed between the various transgenic flies.
Error bars represent the standard deviation.
(E–G) Male flies of the indicated genotype were infected with E. faecalis (E), S. epidermidis (F), or E. coli (G). Each infection was done with at least 25 flies for
each genotype, and the surviving flies were counted daily. Log-rank analysis demonstrated a statistically significant difference between survival of dMyD88-FL
flies and dMyD88 mutants (p % 0.0001) for both E. faecalis and S. epidermidis infections, but not after E. coli infection (p = 0.1986). Survival of dMyD88-FL
flies and dMyD88-Cyto flies was statistically significant after treatment with E. faecalis (p = 0.0091) and S. epidermidis (p = 0.0020), but not after E. coli infection
(p = 0.2673). The difference between survival of dMyD88-FL flies and dMyD88-PLC was not significant for any of the above infections. See also Figure S3.
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Figure 4. Phosphoinositide Binding by dMyD88 Is Necessary for AMP Expression and Restricting Bacterial Load
(A and B) dMyD88 homozygous mutant flies complemented with dMyD88-FL, dMyD88-PLC, and dMyD88-Cyto were challenged by septic injury with E. faecalis
(A) or S. epidermidis (B). Total RNA extracts from 10 flies of each genotype were analyzed for Drosomyocin andMetchnikowin induction by quantitative RT-PCR
both at baseline and 4 hr after infection. Error bars represent the standard deviation.
(C) Individual male flies of the indicated genotype were injected with E. faecalis and homogenized 0.5 or 8 hr after infection. Serial dilutions of the homogenized
flies were plated on kanamycin-containing agar plates to determine bacterial loads. Due to large variances, the data in (C) was log transformed for statistical
analysis. *p < 0.05, **p < 0.01, Student’s t test. See also Figure S4.
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dMyD88 Is a Sorting Adaptorsome flies having bacterial loads as high as the null mutants and
others having bacterial loads as low as dMyD88-FL flies. These
results suggest that a diffusion-mediated process of dMyD88
recruitment results in an unreliable antimicrobial response,
which probably explains the decreased ability of dMyD88-Cyto
flies to survive bacterial infections. Collectively, these data indi-
cate that membrane localization is necessary for maximal Toll
signaling inDrosophila, and that the C-terminal phosphoinositidebinding domain of dMyD88 is both necessary and sufficient for
dMyD88 localization and antimicrobial functions.
The C-terminal Phosphoinositide-Binding Domain of
dMyD88 Is Necessary for Toll Signaling in Development
In addition to its role in fly immunity, dMyD88 is maternally
required for the establishment of the dorsoventral axis during
Drosophila embryogenesis (Charatsi et al., 2003; KambrisImmunity 36, 612–622, April 20, 2012 ª2012 Elsevier Inc. 617
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Figure 5. The Phosphoinositide-Binding Domain of dMyD88 Is
Necessary for Female Fertility
dMyD88 homozygous mutant flies complemented with dMyD88-FL, dMyD88-
PLC, and dMyD88-Cytowith an ovary-specific driver (V32-Gal4) were put to lay
and assayed for the their ability to make viable progeny. The sterility of
dMyD88 homozygous females is complemented by dMyD88-FL and dMyD88-
PLC, but not dMyD88-Cyto. In all cases, at least 50 individual females were
scored. **p < 0.01, Fisher’s exact test.
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transcript renders homozygous dMyD88 mutant females sterile
(Charatsi et al., 2003; Kambris et al., 2002). Thus, to test whether
PIP2 binding by dMyD88 is necessary for development, we
tested homozygous dMyD88mutant flies expressing the various
transgenes for their ability to rescue the sterility phenotype
observed in dMyD88 homozygous females. Consistent with
our finding that plasma membrane localization is necessary for
the function of dMyD88, females expressing the cytosolic allele
(dMyD88-Cyto) failed to produce viable progeny (Figure 5). In
contrast, both the full-length and the PLC alleles restored female
fertility (Figure 5). Taken together, these data indicate that
plasma membrane localization of dMyD88 is necessary for its
developmental function.
dMyD88 Functions to Recruit Tube to the Plasma
Membrane
Until recently, it was assumed that Toll signaling occurred at the
plasma membrane. Our data fully support this idea and suggest
that PIP2-rich regions of the plasmamembrane are the preferred
site of Toll signaling. However, recent reports claim that Toll
signaling occurs from an endocytic compartment (Huang et al.,
2010; Lund et al., 2010). We reasoned that if dMyD88 is indeed
functioning as a sorting adaptor, then it must recruit a signaling
adaptor to the site of signaling. Given the genetic and biochem-
ical data placing the adaptor Tube downstream of dMyD88 (Sun
et al., 2002; Sun et al., 2004), we hypothesized that Tube would
serve the role of the signaling adaptor. To address this predic-
tion, we first needed to know where in the cell Tube resides. Ex-
pressing Tube in S2 cells revealed that Tube is found to be evenly
distributed throughout the cytosol (Figure 6A). Given that Tube
localization differed from dMyD88, we next examined whether
dMyD88 was capable of recruiting Tube to the plasma mem-
brane in a signaling domain dependent manner. To address
this question, we coexpressed Tube with full-length dMyD88
or a dMyD88 mutant lacking the death domain. Under both
conditions, dMyD88 localized to the plasma membrane, further618 Immunity 36, 612–622, April 20, 2012 ª2012 Elsevier Inc.validating that its localization is independent of its signaling
domains. Tube, on the other hand, was no longer observed to
be cytosolic when coexpressed with full-length dMyD88. Rather,
Tube colocalized with full-length dMyD88 at the plasma mem-
brane (Figure 6B). This colocalization was not observed when
Tube was expressed with the dMyD88 mutant lacking the death
domain, indicating that a signaling domain is necessary for the
observed cell surface recruitment (Figure 6B). Collectively, our
results, along with previous in vivo data showing dMyD88-
dependent Tube localization at the plasma membrane (Sun
et al., 2004), suggest that signaling is at least initiated at the
plasma membrane and that the subcellular localization of
dMyD88 prepositions this adaptor to recruit downstream
signaling proteins.
The C-terminal Extension Is Conserved throughout
Invertebrate Evolution
To determine whether the properties of dMyD88 represent a
common theme in the invertebrate lineage, we analyzed the
MyD88 gene from other insect species for the presence of a
CTE. All insect species analyzed had a CTE connected to the
TIR domain of their MyD88 gene (Figure S5). Interestingly,
none of these invertebrate species had a TIRAP homolog (Fig-
ure S5). In contrast to what we observed in the insect lineage,
among the vertebrate species that we analyzed, none had a
MyD88 allele with additional sequence after the TIR domain,
but all had a TIRAP homolog (Figure S5). The strong correlation
between the presence of the CTE and the absence of a TIRAP
homolog supports our hypothesis that this localization domain
endows MyD88 with sorting adaptor function. To further test
this hypothesis, we cloned theMyD88 gene from a clinically rele-
vant insect species and determined its localization. Specifically,
we expressed the MyD88 homolog from Anopheles gambiae
(AgMyD) in S2 cells and found that AgMyD localizes to the
plasma membrane (Figure 7A). Because AgMyD localized to
the cell surface, we were prompted to investigate whether its
distribution overlapped with dMyD88 localization. When coex-
pressed within the same cell, AgMyD colocalized with dMyD88
at the plasma membrane (Figure 7B). These results suggest
that localization of MyD88 to the plasma membrane is a funda-
mental principle of insect Toll signaling.
DISCUSSION
Research performed on the innate immune responses of
Drosophila has undoubtedly contributed to our current knowl-
edge of the mammalian TLR network. However, in an interesting
twist of events, we now have a more advanced understanding of
the cell biology of TLR signaling in mammals than the ancestral
Toll pathway in flies. For example, it has become increasingly
clear that the mammalian TLRs and their adaptors depend on
basic cell biological trafficking factors for their subcellular local-
ization and signaling functions. Whether the cell biological
‘‘rules’’ that govern TLR signaling in mammals applies to lower
eukaryotes is unknown. A potential explanation for this gap in
our knowledge is that the known mammalian adaptors that
exhibit interesting cell biological properties, such as the sorting
adaptors TIRAP and TRAM, are not found in flies. Although there
are no obvious homologs for these sorting adaptors, the
Figure 6. dMyD88 Recruits Tube to the Plasma
Membrane
(A) S2 cells were transfected with FLAG-Tube and stained
with FLAG antibodies.
(B) S2 cells were cotransfected with either full-length
dMyD88 (YFP-FL) or a dMyD88 mutant lacking the death
domain (YFP-DDD) and Tube. The dMyD88 vectors were
under the control of themetallothionein promoter; thus, for
inducing expression of these constructs, 500 mM CuSO4
was added to the cells 6 hr after transfection. Forty-eight
hours after CuSO4 induction, Tube is redistributed to the
cell surface with full-length dMyD88, but not the DDD
mutant. All images are representative of at least three
independent experiments in which >500 cells were
examined per condition and >95% of the cells displayed
similar staining. Scale bars represent 5 mm.
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dMyD88 Is a Sorting Adaptorreceptor proximal complex found in flies displays notable
symmetry to the receptor proximal complex found in mammals.
For example, both the mammalian and fly pathways rely on two
adaptor proteins to bridge the activated receptor to downstream
kinases. From this comparison, we considered the idea that
the fly adaptors serve equivalent roles to the mammalian sort-
ing-signaling adaptor pair. In particular, we hypothesized that
dMyD88 functions as a sorting adaptor. In all cell biological
assays performed, dMyD88 does not behave as its mammalian
namesake, but rather phenocopies the sorting adaptor TIRAP.
Like TIRAP, dMyD88 is localized to the plasma membrane at
steady state in the absence of Toll signaling, and this plasma
membrane localization is mediated by a C-terminal phosphoino-
sitide-binding domain. Moreover, just as TIRAP can recruit
MyD88 to the plasma membrane by a process dependent on
its signaling domain (Kagan and Medzhitov, 2006), dMyD88
can recruit the downstream adaptor Tube to the plasma
membrane by a similar process. Taken together, our cell biolog-
ical and genetic analyses suggest that dMyD88 is functionally a
sorting adaptor.
Although the idea that protein localization is important for
adaptor function has attracted much attention, the importance
of this localization in preventing infections in vivo has remained
unclear. Our findings that transgenic flies containing dMyD88-
Cyto exhibit defects in AMP expression, control of bacterial repli-
cation, and ultimately survival demonstrate the fundamental
importance of sorting adaptor localization for immune defenseImmunity 36in vivo. Moreover, our additional finding that
dMyD88-PLC can complement the immune
defects of dMyD88 mutant flies suggests that
the only activity needed within the C-terminal
localization domain is the ability to bind PIP2.
Thus, we propose that PIP2 in the primarymedi-
ator of dMyD88 localization in flies.
Because PIP2 is enriched at the plasma
membrane, our suggestion that this lipid is the
primary mediator of dMyD88 localization
implies that Toll signaling occurs at the cell
surface. Recently, however, this idea has been
contested by reports indicating that endocy-
tosis is necessary for the proper activation ofthe Toll pathway (Huang et al., 2010; Lund et al., 2010). From
its comparison to mammalian TLRs that activate signal trans-
duction after receptor internalization, the discovery that endocy-
tosis is necessary for the Drosophila Toll pathway suggests an
evolutionarily conserved role for endocytosis in Toll signaling.
Although this parallel is intriguing, there are important differ-
ences between these two pathways that indicate that endocy-
tosis does not play similar roles in flies and mammals. One
notable difference is that the mammalian TLRs require endocy-
tosis to activate a second signaling pathway that is induced
uniquely from endosomes (Kagan et al., 2008; Tanimura et al.,
2008). For example, in the best-characterized mammalian
system, TLR4 first signals from the plasmamembrane to activate
NF-kB, and then later switches to the IRF3 activating pathway
that is induced from endosomes. The Drosophila Toll pathway,
on the other hand, is not known to induce distinct signaling
pathways. Rather, flies activate a single dMyD88-Tube-
dependent pathway that results in AMP expression (Tauszig-
Delamasure et al., 2002). Although endocytosis may be involved
in thisDrosophila pathway, our results suggest that Toll signaling
is at least initiated at the plasma membrane. We provide
several lines of evidence to support this idea. First, dMyD88
recruits Tube to the plasma membrane. This recruitment only
occurs in a signal-dependent manner because dMyD88mutants
lacking the death domain are incapable of delivering Tube to the
cell surface. Second, dMyD88-PLC rescues the immune pheno-
type observed in dMyD88 mutants. As stated above, the PH, 612–622, April 20, 2012 ª2012 Elsevier Inc. 619
Figure 7. The Presence of a C-terminal Extension
Is Conserved within the Insect Lineage
(A) S2 cells were transfected with FLAG-AgMyD and
stained with FLAG antibodies.
(B) Fluorescence micrographs of S2 cells expressing
YFP-dMyD88 and FLAG-AgMyD. All images are repre-
sentative of at least three independent experiments in
which >500 cells were examined per condition and >95%
of the cells displayed similar staining. Scale bars represent
5 mm. See also Figure S5.
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dMyD88 Is a Sorting Adaptordomain of PLCd1 binds to PIP2, which is highly enriched at
the cell surface and virtually absent from endosomes. In fact,
during endocytosis, PIP2 concentrations fall so drastically (Bo-
telho et al., 2000) that it is unlikely that dMyD88-PLC would be
present at very high quantities on early endosomes, and thus,
unlikely that Toll signaling would be initiated from this internal
cellular location in these flies. Furthermore, the fact that
dMyD88-PLC signals better even at baseline provides further
credence to the hypothesis that signaling must occur at the
plasma membrane, given that this result implies that dMyD88
localization to the cell surface is a rate-limiting step in the Toll
signaling pathway. Collectively, our data suggest that the initial
site of Toll signaling is from the plasma membrane, but subse-
quent endocytic events may extend the duration of the signaling
response.
It is intriguing, though, that dMyD88-PLC does signal better
than the WT adaptor. As described above, the PH domain
from PLCd1 is an excellent tool to study the sufficiency of
PIP2 binding by dMyD88, because it is one of the only known
domains that binds PIP2 with high affinity in vitro and in vivo
(Lemmon, 2003). If an interaction domain works better to
protect against infection, then why did nature choose to use
the weaker PIP2 binding domain for dMyD88? One hypothesis
is that the weaker PIP2 interacting domain may be evolution-
arily advantageous for Toll signaling in flies. For example, it is
possible that endocytosis is required for Toll signaling and
that the adaptor complex must be released from the membrane
either for downregulation or continuation of the signal. It is also
possible that the weaker PIP2 binding domain evolved to avoid
constitutively high amounts of AMP production, which have
been shown to be deleterious to the animal. For example,
chronic activation of the Imd pathway leads to altered com-
mensal populations and reduced lifespan (Libert et al., 2006;
Ryu et al., 2008). Although Toll signaling has not be impli-
cated in the regulation of commensal bacteria, it is possible
that such strong baseline signaling as observed with dMyD88-
PLC may affect the fly’s interaction with its commensal620 Immunity 36, 612–622, April 20, 2012 ª2012 Elsevier Inc.microbiota and, thus, may lead to death by al-
lowing noxious bacterial species to dominate
the gut.
In addition to its function in innate immunity,
Toll signaling is important for development in
Drosophila. The protein weckle is the only cyto-
solic factor thus far identified that is selectively
required for Toll signaling in development, and
it has been proposed to function by recruiting
dMyD88 to the plasma membrane to engageToll (Chen et al., 2006). Our data demonstrating that dMyD88
must encode a plasma membrane localization motif for its
signaling functions in development suggest that any interactions
between weckle and dMyD88 are not sufficient for plasma
membrane recruitment and signaling. It is therefore possible
that weckle acts at a different stage of Toll signaling, perhaps
downstream of the sorting-signaling adaptors dMyD88 and
Tube.
Although this study has focused on the role that dMyD88 plays
in Toll signaling, our results also highlight the functional signifi-
cance of Tube. On the basis of the sorting-signaling adaptor
paradigm established in mammalian cells, our data indicate
that Tube is the functional equivalent of mammalian MyD88.
Classifying Tube as a signaling adaptor strengthens the analogy
to the mammalian system, but it raises the question of why there
is a need for these sorting-signaling pairs in flies. In the mamma-
lian network, not all TLRs use the same adaptors (Akira and
Takeda, 2004). For example, many plasma membrane-localized
TLRs utilize both TIRAP and MyD88, whereas only MyD88 is
needed for signaling by TLRs found on endosomes. The fact
that MyD88 is needed in both subcellular compartments
suggests that sorting adaptors, like TIRAP, evolved to recruit
MyD88 to the proper signaling location. On the basis of this
evolutionary perspective, we speculate that the need for
dMyD88 evolved because Tube functions in additional locations
within the cell. Eight other Tolls have been identified in flies
(Tauszig et al., 2000), but few (if any) play a role in immunity. It
is possible that the other Tolls are needed for various immune
responses not yet characterized, and that these immune
responses occur in a different cellular location than at the plasma
membrane. Thus, based on the analogy to the mammalian
system, dMyD88 would have evolved to bring the signaling
adaptor Tube to the plasma membrane, whereas other sorting
adaptors may be required to recruit Tube to other signaling
locations. Further characterization of other Tolls and their depen-
dence on the known adaptor molecules is needed to address
this possibility.
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Cell Culture, Transfections, and Immunofluorescence
S2 cells were maintained at 25C in Schneider’s Drosophila medium (GIBCO)
supplemented with 10% FBS and 1% penicillin and streptomycin. Cells were
transfected with 1 mg of expression vector with Fugene 6 in accordance to the
manufacturer’s protocol (Roche). Forty-eight hours after transfection, cells
were washed in serum-free media and then incubated on alcian blue cover-
slips for 30 min prior to fixation. Cells were fixed at 25C in 2% paraformalde-
hyde for 20min, made permeable for 10min with 1X phosphate buffered saline
(PBS) + 0.1% Triton-X, and incubated with block buffer (2% goat serum,
50 mM ammonium chloride in PBS) for 30 min. Samples were then incubated
with the appropriate antibodies diluted in block buffer. Antibody binding was
detected with AlexaFluor secondary antibodies from Molecular Probes and
visualized with a spinning-disk confocal microscope (Zeiss Axiovert 200M).
Images were captured and analyzed with Slidebook 5.0 software (Intelligent
Imaging Innovations). Primary bone marrow-derived macrophages from
wild-type (C57B6) mice were prepared as previously described (Kagan and
Roy, 2002). Macrophages were transfected by nucleofection (AMAXA) with
the mouse macrophage transfection reagent. After transfection, the cells
were plated on coverslips and incubated at 37C for 4 hr prior to fixing. Staining
of macrophages was performed as described above for S2 cells, except that
AlexaFluor 647-phalloidin (Molecular Probes) was includedwith the secondary
antibody to identify F-actin.
Protein Purification and Lipid Binding Assays
GST-fusion proteins were purified from BL21 E. coli using glutathione Sephar-
ose 4B (Amersham) in accordance to the manufacturer’s instructions. Purity of
each GST preparation was confirmed by SDS-PAGE and Coomassie staining.
PIP strips and PIP arrays were performed as previously described (Kagan and
Medzhitov, 2006). Quantitative lipid pull-down assays were performed as
previously described (Kagan and Medzhitov, 2006), except that 10 mg of
each GST protein were mixed with 50 mg of liposomes containing 18% of
the indicated phosphoinositide. Fluorescence recovered by beads coated
with GST-mMyD88 was subtracted from each sample to account for nonspe-
cific binding of liposomes to the beads.
Fly Strains and Crosses
All flies were maintained at 25C on a standard cornmeal medium. The mutant
strains used in this study (PBc03881 and key) have been previously described
(Kambris et al., 2003; Rutschmann et al., 2000). Transgenic flies were
generated by P-element transformation of w1118 embryos with standard
procedures (Rainbow Transgenic Flies, Inc.). Constructs used for generating
transgenic flies were created by cloning dMyD88-FL (nucleotides 1–1614)
and dMyD88-Cyto (nucleotides 1–1158) into pUAST (Brand and Perrimon,
1993). For the dMyD88-PLC chimera, the N-terminal sequence (nucleotides
1-1158) was fused to the PH domain of PLCd1 by overlap extension PCR
and then cloned into pUAST. Each construct was crossed into the dMyD88
homozygous mutant background, along with the hs-Gal4 driver for all infection
assays. The genotype of these flies was dMyD88c03881, hsGal4/dMyD88c03881,
and UAS-dMyD88 transgene (for which the transgene is dMyD88-FL,
dMyD88-PLC, or dMyD88-Cyto). Because of the known leakiness of the
heat-shock promoter (Kambris et al., 2003; Maurange and Paro, 2002), no
heat shock was necessary in order to express the transgenes. The V32-Gal4
driver (Maxton-KuchenmeisterMaxton-Ku¨ et al., 1999) was used for obtaining
high expression of maternal Gal4 in the sterility assays. At least two indepen-
dent lines were tested in every experiment for each dMyD88 transgene. Homo-
zygous dMyD88 mutant flies (dMyD88c03881/dMyD88c03881) and wild-type
dMyD88 heterozygotes (dMyD88c03881/CyO) were used as controls.
Infection Experiments
Septic injury was performed by pricking 2- to 4-day-old male flies with a tung-
sten needle previously dipped in a pellet from an overnight culture of E. faecalis
(ATCC number 10100),S.epidermidis (gift from P.Watnik), or E. coli (XL1 Blue).
After bacterial infection, flies were immediately transferred to 29C. Flies that
died in the first 3 hr were discarded. Flies were scored daily for survival exper-
iments or RNA was extracted from the infected flies at the indicated timesusing RNA-Bee (Fisher). RT-PCR was carried out with a Bio-Rad iQ5 real
time cycler with Taqman probes as directed by the manufacturer.
Determination of CFU in Flies
Flies were challenged with an overnight culture of E. faecalis as described
above and incubated at 29C for 8 hr. Individual flies were homogenized in
100 ml of PBS, diluted serially, and spread onto Brain Heart Infusion agar plates
supplemented with 25 mg/mL of kanamycin. It should be noted that no kana-
mycin-resistant bacteria grew out of lysates from noninfected flies.
Plasmids
pJL1-FLAG-dMyD88, pCMV2-FLAG-dMyD88, pJL1-FLAG-Tube, pCMV2-
FLAG-TIRAP, pCMV2-FLAG-mMyD88, and TIRAP-GFP were described
previously (Horng and Medzhitov, 2001; Kagan and Medzhitov, 2006). The
pCMV2-FLAG-dMyD88 vector was used as a template for cloning dMyD88
into pEYFP-C1 (Clonetech) and pGEX4T1 (Amersham). The sequences coding
for the N-terminal (DD+TIR) construct (nucleotides 1-1158) and the CTE vector
(nucleotides 1125-1614) were amplified by PCR with pCMV2-FLAG-dMyD88
as a template and then cloned into either pJL1-FLAG vector (Horng and
Medzhitov, 2001) or pGEX4T1. Metallothionine vectors encoding YFP-FL or
YFP-DDD (nucleotides 709-1614) were generated by subcloning the
YFP-tagged dMyD88 cDNAs from pEYFP-C1 into pJL252 (Horng andMedzhi-
tov, 2001). The AgMyD gene was cloned into the pJL1-FLAG vector by
amplifying the AgMyD from Anopheles gambiae cDNA with the following
forward and reverse primers (F: 50-ATGTTGGATAATCCCGTAAAACC-30;
R: 50-TTACACAGCGCTAGCTAGTTTTC-30).
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